BLU — BELLUS Health Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- CA$2.47bn
- CA$2.06bn
- $0.02m
Annual income statement for BELLUS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.027 | 0.027 | 0.015 | 0.016 | 0.016 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.67 | 25.8 | 33 | 73.3 | 77.9 |
| Operating Profit | -7.64 | -25.7 | -32.9 | -73.3 | -77.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -7.01 | -26 | -31.8 | -71.4 | -76 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.209 | -0.548 | -0.538 | -0.898 | -0.66 |